An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia

Even with an efficient combination of antiretroviral therapy (ART), which significantly decreases viral load in human immunodeficiency virus type 1 (HIV-1)-positive individuals, the occurrence of HIV-1-associated neurocognitive disorders (HAND) still exists. Microglia have been shown to have a signi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Viruses
Hlavní autoři: Gong, Yuqing, Zhi, Kaining, Nagesh, Prashanth K. B., Sinha, Namita, Chowdhury, Pallabita, Chen, Hao, Gorantla, Santhi, Yallapu, Murali M., Kumar, Santosh
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7290679/
https://ncbi.nlm.nih.gov/pubmed/32443728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v12050564
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky